So YC Bio doesn't imply a much bigger investment for 20% equity anymore?
Most bio startups will require a significant amount of capital to bootstrap. It's cheaper now, but still an order of magnitude more than for IT.
Most bio startups will require a significant amount of capital to bootstrap. It's cheaper now, but still an order of magnitude more than for IT.
https://blog.ycombinator.com/how-biotech-startup-funding-wil...
https://techcrunch.com/2019/08/09/biotech-researchers-ventur...
Case in point - Asher Bio from the most recent YC batch went from zero to a working molecule & in-vivo data in ~3 months on the standard deal - https://techcrunch.com/2019/08/20/here-are-the-82-startups-t...